CAPONE, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 222
EU - Europa 200
AS - Asia 135
SA - Sud America 10
AF - Africa 1
Totale 568
Nazione #
US - Stati Uniti d'America 215
IT - Italia 100
SG - Singapore 45
UA - Ucraina 32
CN - Cina 24
TR - Turchia 23
VN - Vietnam 19
DE - Germania 15
SE - Svezia 14
HK - Hong Kong 13
FI - Finlandia 10
FR - Francia 10
BR - Brasile 8
IE - Irlanda 8
CA - Canada 4
IN - India 4
GB - Regno Unito 3
PL - Polonia 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
JP - Giappone 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
HN - Honduras 1
IQ - Iraq 1
PK - Pakistan 1
PY - Paraguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 568
Città #
Milan 71
Chandler 34
Jacksonville 24
San Jose 22
Singapore 20
Dallas 12
Hong Kong 12
Ashburn 11
Beijing 11
Dearborn 11
Izmir 11
Nyköping 10
New York 9
Dublin 8
Princeton 8
Ho Chi Minh City 7
Munich 6
Wilmington 6
Boardman 5
Como 5
Los Angeles 5
The Dalles 5
Brooklyn 4
Chicago 4
Dong Ket 4
Lauterbourg 4
Rome 4
Woodbridge 4
Pune 3
San Mateo 3
Warsaw 3
Fairfield 2
Houston 2
Montreal 2
Santa Clara 2
Seattle 2
Tokyo 2
Vanzaghello 2
Adana 1
Atlanta 1
Belo Horizonte 1
Berlin 1
Brampton 1
Brno 1
Campinas 1
Charleston 1
Chennai 1
Clarksburg 1
Corrientes 1
Da Nang 1
Denver 1
Duhok 1
Düsseldorf 1
Edinburgh 1
Guangzhou 1
Haiphong 1
Helsinki 1
Huzhou 1
Jales 1
Johannesburg 1
Lahore 1
Laranjal Paulista 1
Lauro de Freitas 1
Manchester 1
Mexico City 1
Milwaukee 1
Nanchang 1
Olomouc 1
Orem 1
Peterborough 1
Querétaro 1
Quảng Ngãi 1
Rozzano 1
San Diego 1
San Pedro Sula 1
Staten Island 1
São Paulo 1
Tashkent 1
Tulsa 1
Turku 1
Ubá 1
Verona 1
Villa Elisa 1
Votorantim 1
Vũng Tàu 1
Xian 1
Totale 408
Nome #
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells. 144
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy. 143
CIITA-transfected tumor cells as potent, widely applicable anti-tumor vaccine due to their optimal triggering of long-lasting tumor-specific CD4+ T helper cells 142
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy. 139
Totale 568
Categoria #
all - tutte 1.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 4 9
2021/202229 0 4 3 4 1 0 1 3 2 4 2 5
2022/202378 5 7 3 11 5 14 0 10 10 4 6 3
2023/2024119 17 20 18 21 21 17 0 0 0 2 1 2
2024/202570 0 1 10 4 3 1 2 3 13 8 6 19
2025/2026138 15 8 6 24 17 10 32 12 11 3 0 0
Totale 568